Imagion Biosystems Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced total revenue was AUD 2.780 million compared to AUD 2.312 million a year ago. Net loss was AUD 1.450 million compared to AUD 1.738 million a year ago. Basic loss per share from continuing operations was AUD 0.0014 compared to AUD 0.0029 a year ago.